✦ LIBER ✦

Donepezil HCl (E2020) Maintains Functional Brain Activity in Patients With Alzheimer Disease: Results of a 24-Week, Double-Blind, Placebo-Controlled Study

✍ Scribed by Tune, Larry; Tiseo, Paul J.; Ieni, John; Perdomo, Carlos; Pratt, Raymond D.; Votaw, John R.; Jewart, R.D.; Hoffman, John M.

Book ID: 122705864
Publisher: American Psychiatric Publishing Inc
Year: 2003
Tongue: English
Weight: 793 KB
Volume: 11
Category: Article
ISSN: 1064-7481
DOI: 10.1097/00019442-200303000-00007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 24-week, double-blind, placebo-control

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease—pilot study

✍ Vee. P. Prasher; Adam Huxley; M. S. Haque 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

## Abstract ## Background Donepezil Hydrochloride (Aricept) is a selective anticholinesterase inhibitor developed for the treatment of Alzheimer's disease (AD). This study investigated the safety and efficacy of the drug to treat Down syndrome (DS) adults with mild to moderate AD. ## Method This

A 24-week, double-blind, placebo-control

A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease

✍ X. A. Alvarez; R. Cacabelos; M. Laredo; V. Couceiro; C. Sampedro; M. Varela; L. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

A Randomized, Double-Blind, Placebo-Cont

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease in the Nursing Home Setting

✍ Pierre N. Tariot; Jeffrey L. Cummings; Ira R. Katz; Jacobo Mintzer; Carlos A. Pe 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

A 24-week, randomized, double-blind, pla

A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of the rivastigmine patch in Japanese patients with Alzheimer's disease

✍ Nakamura, Yu; Imai, Yukimichi; Shigeta, Masahiro; Graf, Ana; Shirahase, Toru; Ki 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Changes of biological markers and brain

Changes of biological markers and brain PET imaging and clinical effects of memantine for patients with moderate to severe Alzheimer's disease: A 24-week double-blind, randomized, placebo-controlled study

✍ Shifu Xiao; Tao Wang; Qiu Huang; Kewei Chen; Eric Reiman 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

A multicenter, double-blind, placebo-con

A multicenter, double-blind, placebo-controlled phase IIb proof-of-concept dose-ranging study of AZD3480 and donepezil over 12 weeks in patients with mild to moderate Alzheimer's disease

✍ Lutz Frölich; Göran Eckerwall; Nilsson Jonas 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB